Similar articles

• Bacillus Calmette-Guerin (BCG) lymphadenitis-changing trends and management.

  Nazir Z, Qazi SH. Nazir Z, et al. J Ayub Med Coll Abbottabad. 2005 Oct-Dec;17(4):16-8. J Ayub Med Coll Abbottabad. 2005. PMID: 16599027
• Evaluating clinical course of BCG lymphadenitis and factors affect on it during a 5-year period in Kerman, Iran.

  Daei Parizi M, Kardoust Parizi A, Izadipour S. Daei Parizi M, et al. J Trop Pediatr. 2014 Apr;60(2):148-53. doi: 10.1093/tropej/fmt100. Epub 2013 Dec 10. J Trop Pediatr. 2014. PMID: 24327454
• [Lymphadenitis as a complication following vaccination with Bacillus Calmette-Guérin (BCG)].

  Cerdá de Palou E, de Santy HP. Cerdá de Palou E, et al. Ned Tijdschr Geneeskd. 2003 Mar 22;147(12):569-72. Ned Tijdschr Geneeskd. 2003. PMID: 12693089 Dutch.
• [The uses and effects of the Calmette-Guérin Mycobacterium bovis bacillus (BCG Vaccination)].

  López-Antuñano FJ. López-Antuñano FJ. Salud Publica Mex. 1997 Mar-Apr;39(2):156-61. Salud Publica Mex. 1997. PMID: 9254441 Review. Spanish. No abstract available.
• Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccination against tuberculosis in humans, veterinary animals and wildlife species.

  Murphy D, Corner LA, Gormley E. Murphy D, et al. Tuberculosis (Edinb). 2008 Jul;88(4):344-57. doi: 10.1016/j.tube.2007.11.010. Epub 2008 Jan 28. Tuberculosis (Edinb). 2008. PMID: 18222731 Review.